Implications of the Diabetes Control and Complications Trial
- 1 January 2003
- journal article
- guideline
- Published by American Diabetes Association in Diabetes Care
- Vol. 26 (suppl_1), s25-s27
- https://doi.org/10.2337/diacare.26.2007.s25
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38BMJ, 1998
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Lifetime Benefits and Costs of Intensive Therapy as Practiced in the Diabetes Control and Complications TrialJAMA, 1996
- Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research GroupJAMA, 1996
- The Absence of a Glycemic Threshold for the Development of Long-Term Complications: The Perspective of the Diabetes Control and Complications TrialDiabetes, 1996
- Long-Term Glycemic Control Relates to Mortality in Type II DiabetesDiabetes Care, 1995
- The Relationship of Glycemic Exposure (HbA1c) to the Risk of Development and Progression of Retinopathy in the Diabetes Control and Complications TrialDiabetes, 1995
- Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year studyDiabetes Research and Clinical Practice, 1995
- Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in Type 2 (non-insulin-dependent) diabetic and non-diabetic subjectsDiabetologia, 1993
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993